Breaking News Instant updates and real-time market news.

HRTX

Heron Therapeutics

$32.10

0.4 (1.26%)

08:48
05/17/18
05/17
08:48
05/17/18
08:48

Heron upcoming Phase IIb data likely positive, says Jefferies

Jefferies analyst Biren Amin believes Heron Therapeutics' HTX-011 Phase IIb study in total knee arthroplasty is "poised for success." The analyst anticipates a positive outcome on the late Q2 readout. On positive data, the shares will likely rally 15%-20%, Amin tells investors in a research note. He sees downside of 10% if the study misses statistical significant but is still clinically relevant. The analyst keeps a Buy rating on Heron with a $38 price target.

HRTX Heron Therapeutics
$32.10

0.4 (1.26%)

04/12/18
COWN
04/12/18
NO CHANGE
COWN
Draft bill could be good for Heron, seems to exclude Pacira drug, says Cowen
Cowen analyst Boris Peaker said a draft bill creating a pass-through payment for non-opioid analgesics as part of surgical procedures appears to exclude Pacira's (PCRX) Exparel, but could benefit Heron Therapeutics' (HRTX) HTX-011. He also noted, though, that several bills would promote the use of local anesthetics. The House E&C committee is planning to move into more formal legislative drafting mode with the goal of reporting legislation out before Memorial Day, Peaker added.
04/20/18
MZHO
04/20/18
NO CHANGE
MZHO
Buy
Helsinn CINV product no threat to Heron Therapeutics, says Mizuho
Mizuho analyst Difei Yang noted that privately held Helsinn Group received FDA approval for an IV formulation of its chemotherapy-induced nausea and vomiting, or CINV, product and plans to launch it in May through its U.S. subsidiary. However, she does not expect the company's IV formulation to pose a threat to Heron Therapeutics' CINV franchise and sees this news as "a non-event for Heron." Yang keeps a Buy rating on Heron shares.
04/23/18
CANT
04/23/18
NO CHANGE
Target $40
CANT
Overweight
Doctor call supports Cantor's positive thesis on Heron Therapeutics
After hosting a conference call with two physicians to better understand how HTX-011 will fit into the post-operative pain market, Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Heron Therapeutics (HRTX) with a $40 price target. Both physicians do not see Pacira Pharmaceuticals' (PCRX) Exparel being used anymore if HTX-011 is approved, Chen tells investors in a research note. The doctors believe that HTX-011 is a better drug that is likely to be priced lower than Exparel, the analyst points out. Chen says the call supports her positive thesis on Heron.
05/03/18
EVER
05/03/18
NO CHANGE
Target $56
EVER
Outperform
Surgeon sees Heron's HTX-011 poised for 'meaningful' success, says Evercore
Evercore ISI analyst Josh Schimmer said his discussion with a general and bariatric surgeon involved in protocol development, but not an investigator, in the HTX-011 studies amounted to "a strong vote of confidence." While the surgeon's center deemed Exparel did not deliver adequate value relative to its benefit, he said he would use HTX-011 "in virtually every surgical setting," according to Schimmer, who has a $56 price target and Outperform rating on Heron Therapeutics shares.

TODAY'S FREE FLY STORIES

TJX

TJX

$105.94

4.26 (4.19%)

11:19
08/21/18
08/21
11:19
08/21/18
11:19
Earnings
TJX raises FY19 revenue view to $38.2B-$38.4B from $37.7B-$37.9B, consensus $38B »

Still expects pretax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TOL

Toll Brothers

$38.82

4.1 (11.81%)

11:18
08/21/18
08/21
11:18
08/21/18
11:18
Hot Stocks
Breaking Hot Stocks news story on Toll Brothers »

Toll Brothers sees FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

STLR

Stellar Acquisition III

$10.50

(0.00%)

11:17
08/21/18
08/21
11:17
08/21/18
11:17
Conference/Events
Stellar Acquisition III to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/21/18
08/21
11:17
08/21/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$39.13

4.41 (12.70%)

11:16
08/21/18
08/21
11:16
08/21/18
11:16
Hot Stocks
Breaking Hot Stocks news story on Toll Brothers »

Toll Brothers sees FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/21/18
08/21
11:16
08/21/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
08/21/18
08/21
11:15
08/21/18
11:15
General news
Breaking General news story  »

Week of 8/21 4-Week Bill…

DISCA

Discovery

$28.83

0.91 (3.26%)

, AAPL

Apple

$214.78

-0.7 (-0.32%)

11:13
08/21/18
08/21
11:13
08/21/18
11:13
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

DISCA

Discovery

$28.83

0.91 (3.26%)

AAPL

Apple

$214.78

-0.7 (-0.32%)

MSG

Madison Square Garden

$301.39

4.17 (1.40%)

MSGN

MSG Networks

$25.15

0.3 (1.21%)

TSLA

Tesla

$319.25

10.75 (3.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TOL

Toll Brothers

$39.20

4.48 (12.90%)

11:13
08/21/18
08/21
11:13
08/21/18
11:13
Hot Stocks
Toll Brothers says current backlog gives good visibility through 1H19 »

The company projects FY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

NFLX

Netflix

$339.01

11.26 (3.44%)

, AAPL

Apple

$214.71

-0.77 (-0.36%)

11:10
08/21/18
08/21
11:10
08/21/18
11:10
Hot Stocks
Analyst sees favorable setup ahead for Netflix on international subscriptions »

In a research note this…

NFLX

Netflix

$339.01

11.26 (3.44%)

AAPL

Apple

$214.71

-0.77 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

ROST

Ross Stores

$92.32

-0.01 (-0.01%)

11:10
08/21/18
08/21
11:10
08/21/18
11:10
Options
Defensive option play opened in Ross Stores ahead of earnings »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

11:10
08/21/18
08/21
11:10
08/21/18
11:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

TJX

TJX

$105.50

3.82 (3.76%)

11:09
08/21/18
08/21
11:09
08/21/18
11:09
Hot Stocks
Breaking Hot Stocks news story on TJX »

TJX still sees buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

DISCA

Discovery

$28.80

0.88 (3.15%)

, AAPL

Apple

$214.70

-0.78 (-0.36%)

11:09
08/21/18
08/21
11:09
08/21/18
11:09
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

DISCA

Discovery

$28.80

0.88 (3.15%)

AAPL

Apple

$214.70

-0.78 (-0.36%)

MSG

Madison Square Garden

$301.58

4.36 (1.47%)

MSGN

MSG Networks

$25.15

0.3 (1.21%)

TSLA

Tesla

$318.95

10.45 (3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TJX

TJX

$105.65

3.97 (3.90%)

11:05
08/21/18
08/21
11:05
08/21/18
11:05
Hot Stocks
TJX CEO Ernie Herrman says Q3 'off to a very strong start' »

Comment taken from the Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

PAYX

Paychex

$72.53

0.21 (0.29%)

11:00
08/21/18
08/21
11:00
08/21/18
11:00
Options
Paychex calls active »

Paychex calls active.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

NVDA

Nvidia

$251.67

3.82 (1.54%)

, BIDU

Baidu

$225.00

1.37 (0.61%)

10:57
08/21/18
08/21
10:57
08/21/18
10:57
Hot Stocks
Citron remains cautious on Nvidia, repeats $200 per share forecast »

In a newly published…

NVDA

Nvidia

$251.67

3.82 (1.54%)

BIDU

Baidu

$225.00

1.37 (0.61%)

BABA

Alibaba

$178.80

2.59 (1.47%)

TCEHY

Tencent

$0.00

(0.00%)

FB

Facebook

$173.87

1.37 (0.79%)

GOOG

Alphabet

$1,215.21

7.67 (0.64%)

GOOGL

Alphabet Class A

$1,230.17

8.99 (0.74%)

MSFT

Microsoft

$106.99

0.12 (0.11%)

AMZN

Amazon.com

$1,891.43

15.98 (0.85%)

NFLX

Netflix

$338.51

10.76 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 10

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

DWDP

DowDuPont

$69.29

0.81 (1.18%)

10:50
08/21/18
08/21
10:50
08/21/18
10:50
Options
DowDuPont draws call buyers as shares see strength »

DowDuPont draws call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

XXII

22nd Century

$2.36

0.08 (3.51%)

10:42
08/21/18
08/21
10:42
08/21/18
10:42
Hot Stocks
22nd Century reports order for 3.6M SPECTRUM research cigarette »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.61

1.11 (0.64%)

10:41
08/21/18
08/21
10:41
08/21/18
10:41
Periodicals
Facebook is rating the trustworthiness of its users, Washington Post reports »

Facebook has started to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

AMTD

TD Ameritrade

$56.56

-3.6 (-5.98%)

10:40
08/21/18
08/21
10:40
08/21/18
10:40
Options
Heavy trading in TD Ameritrade as the stock comes under fire »

Heavy trading in TD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNIT

Uniti Group

$21.09

0.57 (2.78%)

10:30
08/21/18
08/21
10:30
08/21/18
10:30
Options
Notable put buying in Uniti Group »

Notable put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$42.71

-0.01 (-0.02%)

10:29
08/21/18
08/21
10:29
08/21/18
10:29
Rumors
Rumor moving shares of Papa John's »

Rumor: Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$40.16

0.16 (0.40%)

10:27
08/21/18
08/21
10:27
08/21/18
10:27
Hot Stocks
American Airlines announces expanded European footprint, modified Asia service »

American Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

DXCM

DexCom

$133.50

1.29 (0.98%)

10:25
08/21/18
08/21
10:25
08/21/18
10:25
Conference/Events
DexCom management to participate in a conference call with Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.